DNA-encoded chemical libraries

The discovery and development of novel drugs for the multitude of targets originating from functional genomic research is a challenging task. While antibodies can nowadays be raised against virtually any given target using phage-display methodologies, a similar "selection/amplification" approach for the facile discovery of low-molecular weight compounds capable of specific binding to protein targets of choice has so far been lacking. The development of DNA-encoded chemical libraries, combined with suitable selection and high-throughput sequencing strategies, holds promises to fill this gap. Here, we review the latest developments in the field of DNA-encoded chemical libraries, commenting on the challenges and opportunities for the different experimental strategies in this rapidly evolving research area, which may gain importance for the future drug discovery process.

[1]  Wang Jing-lin,et al.  In vitro selection and evolution of functional proteins by using ribosome display , 2003 .

[2]  Daniel A Erlanson,et al.  Tethering: fragment-based drug discovery. , 2004, Annual review of biophysics and biomolecular structure.

[3]  David R. Liu,et al.  Highly sensitive in vitro selections for DNA-linked synthetic small molecules with protein binding affinity and specificity. , 2003, Journal of the American Chemical Society.

[4]  Monoclonal antibody to the message sequence Tyr-Gly-Gly-Phe of opioid peptides exhibits the specificity requirements of mammalian opioid receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Barrett,et al.  Differences among techniques for high‐abundant protein depletion , 2005, Proteomics.

[6]  R. Lauffer,et al.  Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. , 1997, Investigative radiology.

[7]  P. Harbury,et al.  DNA Display II. Genetic Manipulation of Combinatorial Chemistry Libraries for Small-Molecule Evolution , 2004, PLoS biology.

[8]  Charles L Brooks,et al.  Albumin binding to FcRn: distinct from the FcRn-IgG interaction. , 2006, Biochemistry.

[9]  Z. Gartner,et al.  The generality of DNA-templated synthesis as a basis for evolving non-natural small molecules. , 2001, Journal of the American Chemical Society.

[10]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[11]  David Clark,et al.  Adverse effects of fluorescein angiography in hypertensive and elderly patients. , 2006, Acta ophthalmologica Scandinavica.

[12]  A. Plückthun,et al.  In vitro selection and evolution of functional proteins by using ribosome display. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Stroud,et al.  Site-directed ligand discovery. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Aebersold,et al.  Proteomics: the first decade and beyond , 2003, Nature Genetics.

[15]  Kurt Wüthrich,et al.  Nmr in drug discovery , 2002, Nature Reviews Drug Discovery.

[16]  D. Pearl,et al.  The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan , 2003, The Journal of experimental medicine.

[17]  P. Harbury,et al.  DNA Display I. Sequence-Encoded Routing of DNA Populations , 2004, PLoS biology.

[18]  J. J. Greene,et al.  Identification of interferon-modulated proliferation-related cDNA sequences. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Frank,et al.  A new general approach for the simultaneous chemical synthesis of large numbers of oligonucleotides: segmental solid supports , 1983, Nucleic Acids Res..

[20]  K. Wüthrich,et al.  Isolation and sequence‐specific DNA binding of the Antennapedia homeodomain. , 1988, The EMBO journal.

[21]  K. Hoogsteen,et al.  The crystal and molecular structure of a hydrogen-bonded complex between 1-methylthymine and 9-methyladenine , 1963 .

[22]  S. Schreiber,et al.  Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[23]  A. Hamilton,et al.  Catalytic unfolding and proteolysis of cytochrome C induced by synthetic binding agents. , 2004, Journal of the American Chemical Society.

[24]  R. S. Gordon,et al.  The metabolism of albumin-bound C14-labeled unesterified fatty acids in normal human subjects. , 1958, The Journal of clinical investigation.

[25]  David R. Liu,et al.  Ordered multistep synthesis in a single solution directed by DNA templates. , 2005, Angewandte Chemie.

[26]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2006 , 2006, Nature Biotechnology.

[27]  J. Jett,et al.  High-speed DNA sequencing: an approach based upon fluorescence detection of single molecules. , 1989, Journal of biomolecular structure & dynamics.

[28]  A. Rich,et al.  Crystal structure of four-stranded Oxytricha telomeric DNA , 1992, Nature.

[29]  Jennifer L. Harris,et al.  PNA encoding (PNA=peptide nucleic acid): from solution-based libraries to organized microarrays. , 2005, Chemistry.

[30]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[31]  J. M. Prober,et al.  A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides. , 1987, Science.

[32]  R. Dolan,et al.  MS-325: albumin-targeted contrast agent for MR angiography. , 1998, Radiology.

[33]  M. Radmacher,et al.  Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[34]  H. Kauffmann,et al.  Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin , 2007, Human & experimental toxicology.

[35]  Marcus Droege,et al.  The Genome Sequencer FLX System--longer reads, more applications, straight forward bioinformatics and more complete data sets. , 2008, Journal of biotechnology.

[36]  Fitzgerald,et al.  In vitro display technologies - new tools for drug discovery. , 2000, Drug discovery today.

[37]  G. Rice,et al.  An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum , 2003, Proteomics.

[38]  A. Marx,et al.  DNA-templated synthesis: more versatile than expected. , 2002, Angewandte Chemie.

[39]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[40]  D. Combs,et al.  Albumin affinity tags increase peptide half-life in vivo. , 2002, Bioorganic & medicinal chemistry letters.

[41]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[42]  E. Tate,et al.  Generation and screening of an oligonucleotide-encoded synthetic peptide library. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Quake,et al.  Sequence information can be obtained from single DNA molecules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Christoph E. Dumelin,et al.  Selection of streptavidin binders from a DNA-encoded chemical library. , 2006, Bioconjugate chemistry.

[45]  Jay Shendure,et al.  Fluorescent in situ sequencing on polymerase colonies. , 2003, Analytical biochemistry.

[46]  W. Bains,et al.  A novel method for nucleic acid sequence determination. , 1988, Journal of theoretical biology.

[47]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[48]  Luca Mannocci,et al.  Silver(I)‐Catalysed Protiodesilylation of 1‐(Trimethylsilyl)‐1‐alkynes , 2005 .

[49]  N. Ede,et al.  Beyond Rf tagging. , 2003, Current opinion in chemical biology.

[50]  R P Murphy,et al.  Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. , 1991, Ophthalmology.

[51]  Samu Melkko,et al.  DNA-encoded chemical libraries for the discovery of MMP-3 inhibitors. , 2008, Bioconjugate chemistry.

[52]  A. Hamilton,et al.  Directed denaturation: room temperature and stoichiometric unfolding of cytochrome C by a metalloporphyrin dimer. , 2003, Journal of the American Chemical Society.

[53]  M. Uhlén,et al.  Solid phase DNA minisequencing by an enzymatic luminometric inorganic pyrophosphate detection assay. , 1993, Analytical biochemistry.

[54]  M. Congreve,et al.  Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.

[55]  Min Zhang,et al.  Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins* , 2002, The Journal of Biological Chemistry.

[56]  Mark E Schurdak,et al.  Affinity-based screening techniques for enhancing lead discovery. , 2004, Current opinion in drug discovery & development.

[57]  DNA‐Encoded Chemical Libraries , 2006 .

[58]  B. Ober,et al.  The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. , 1996, Molecular immunology.

[59]  Gisbert Schneider,et al.  Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.

[60]  M. Ellmerer,et al.  Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[61]  C. Huber,et al.  Analysis of nucleic acids by on-line liquid chromatography-mass spectrometry. , 2001, Mass spectrometry reviews.

[62]  R. Houghten,et al.  Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery , 1991, Nature.

[63]  H Klenow,et al.  Selective elimination of the exonuclease activity of the deoxyribonucleic acid polymerase from Escherichia coli B by limited proteolysis. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[65]  N M Green,et al.  Thermodynamics of the binding of biotin and some analogues by avidin. , 1966, The Biochemical journal.

[66]  R. Houghten.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[67]  D. Rognan,et al.  Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. , 2002, Journal of medicinal chemistry.

[68]  Fei Liu,et al.  Phagemid encoded small molecules for high throughput screening of chemical libraries. , 2004, Journal of the American Chemical Society.

[69]  Sydney Brenner,et al.  Synthetic methods for the implementation of encoded combinatorial chemistry , 1993 .

[70]  G M Whitesides,et al.  A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin. , 1998, Science.

[71]  C. Cantor,et al.  THERMOSTABILITY AND CONFORMATIONAL CHANGES UPON BINDING , 1997 .

[72]  D. Patel,et al.  Guanine residues in d(T2AG3) and d(T2G4) form parallel-stranded potassium cation stabilized G-quadruplexes with anti glycosidic torsion angles in solution. , 1992, Biochemistry.

[73]  Samu Melkko,et al.  On the magnitude of the chelate effect for the recognition of proteins by pharmacophores scaffolded by self-assembling oligonucleotides. , 2006, Chemistry & biology.

[74]  T. Clackson,et al.  Making antibody fragments using phage display libraries , 1991, Nature.

[75]  P. Sharp,et al.  Structure-based design of transcription factors. , 1995, Science.

[76]  A. Wunder,et al.  Antitumor activity of methotrexate‐albumin conjugates in rats bearing a Walker‐256 carcinoma , 1998, International journal of cancer.

[77]  P. Brown,et al.  Yeast microarrays for genome wide parallel genetic and gene expression analysis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[78]  R. B. Merrifield.  Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .

[79]  P. Stayton,et al.  Structural studies of the streptavidin binding loop , 1997, Protein science : a publication of the Protein Society.

[80]  Peter Caravan,et al.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. , 2002, Journal of the American Chemical Society.

[81]  S. Fletcher,et al.  Protein recognition and denaturation by self-assembling fragments on a DNA quadruplex scaffold. , 2007, Angewandte Chemie.

[82]  P C Moody,et al.  The high-resolution crystal structure of a parallel-stranded guanine tetraplex. , 1994, Science.

[83]  H. Arlinghaus,et al.  Applications of mass spectrometry to DNA sequencing. , 1991, Genetic analysis, techniques and applications.

[84]  David R. Liu,et al.  Directing otherwise incompatible reactions in a single solution by using DNA-templated organic synthesis. , 2002, Angewandte Chemie.

[85]  A. Merlo,et al.  Design, construction, and characterization of a large synthetic human antibody phage display library , 2005, Proteomics.

[86]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[87]  D. Combs,et al.  Phosphate ester serum albumin affinity tags greatly improve peptide half-life in vivo. , 2003, Bioorganic & medicinal chemistry letters.

[88]  Dario Neri,et al.  Selection of single domain binding proteins by covalent DNA display. , 2007, Protein engineering, design & selection : PEDS.

[89]  K. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[90]  Christof Baltes,et al.  A portable albumin binder from a DNA-encoded chemical library. , 2008, Angewandte Chemie.

[91]  Sylvain Miraux,et al.  Gadolinium-enhanced small-animal TOF magnetic resonance angiography , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[92]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[93]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[94]  R. Lerner,et al.  Encoded combinatorial chemistry. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[95]  M. Waring,et al.  Stabilization of triple helical DNA by a benzopyridoquinoxaline intercalator. , 1996, Biochemistry.

[96]  D. Hyre,et al.  A streptavidin-biotin binding system that minimizes blocking by endogenous biotin. , 2002, Bioconjugate chemistry.

[97]  David R. Liu,et al.  DNA-Templated Organic Synthesis and Selection of a Library of Macrocycles , 2004, Science.

[98]  Eric T. Boder,et al.  Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.

[99]  Harren Jhoti,et al.  High-throughput crystallography for lead discovery in drug design , 2002, Nature Reviews Drug Discovery.

[100]  B. Posner,et al.  High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics. , 2005, Current opinion in drug discovery & development.

[101]  Christoph E. Dumelin,et al.  Isolation of high-affinity trypsin inhibitors from a DNA-encoded chemical library. , 2007, Angewandte Chemie.

[102]  H. Preuss,et al.  Presence of a serum vasoconstrictive factor following unilateral nephrectomy. , 1988, American journal of hypertension.

[103]  H. Haisma,et al.  A facile method for the labeling of proteins with zirconium isotopes. , 1996, Nuclear medicine and biology.

[104]  A. Wunder,et al.  Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate. , 1999, Anti-cancer drugs.

[105]  P. T. Jones,et al.  Isolation of high affinity human antibodies directly from large synthetic repertoires. , 1994, The EMBO journal.

[106]  M. Ronaghi,et al.  Real-time DNA sequencing using detection of pyrophosphate release. , 1996, Analytical biochemistry.

[107]  P. Harbury,et al.  DNA Display III. Solid-Phase Organic Synthesis on Unprotected DNA , 2004, PLoS biology.

[108]  Christoph E. Dumelin,et al.  High-throughput sequencing allows the identification of binding molecules isolated from DNA-encoded chemical libraries , 2008, Proceedings of the National Academy of Sciences.

[109]  Paul Bernard,et al.  The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents. , 2002, Journal of medicinal chemistry.

[110]  R. Falchetto,et al.  SpeedScreen: label-free liquid chromatography-mass spectrometry-based high-throughput screening for the discovery of orphan protein ligands. , 2004, Analytical biochemistry.

[111]  Kit S Lam,et al.  A novel peptide-based encoding system for "one-bead one-compound" peptidomimetic and small molecule combinatorial libraries. , 2002, Journal of the American Chemical Society.

[112]  David R. Liu,et al.  Multistep small-molecule synthesis programmed by DNA templates. , 2002, Journal of the American Chemical Society.

[113]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[114]  R. Strausberg,et al.  From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes , 2003, Science.

[115]  V. Hillier,et al.  Ethnic variation in fluorescein angiography induced nausea and vomiting , 2001, Eye.

[116]  Christoph E. Dumelin,et al.  Encoded self-assembling chemical libraries , 2004, Nature Biotechnology.

[117]  Tom L Blundell,et al.  High-throughput X-ray crystallography for drug discovery. , 2004, Current opinion in pharmacology.

[118]  K. Matsui,et al.  Facile preparation of DNA-tagged carbohydrates. , 2003, Bioorganic & medicinal chemistry letters.

[119]  M. Otagiri,et al.  Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin , 2002, Pharmaceutical Research.

[120]  David R. Liu,et al.  DNA-templated organic synthesis: nature's strategy for controlling chemical reactivity applied to synthetic molecules. , 2004, Angewandte Chemie.

[121]  Min Zhang,et al.  The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin. , 2006, Protein engineering, design & selection : PEDS.

[122]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[123]  Luca Mannocci,et al.  First Total Synthesis of Naturally Occurring (−)-Nitidon and Its Enantiomer , 2004 .

[124]  S. Brack,et al.  Recombinant antibodies for the depletion of abundant proteins from human serum , 2006, Proteomics.

[125]  Constance E. Brinckerhoff,et al.  Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.

[126]  B. Pettitt,et al.  Stabilities of double- and triple-strand helical nucleic acids. , 1992, Progress in biophysics and molecular biology.

[127]  Á. Furka,et al.  General method for rapid synthesis of multicomponent peptide mixtures. , 2009, International journal of peptide and protein research.

[128]  T. Peters,et al.  All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .

[129]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[130]  G. Holdgate,et al.  Isothermal titration calorimetry in drug discovery. , 2001, Progress in medicinal chemistry.

[131]  Mahesh Uttamchandani,et al.  Small molecule microarrays: recent advances and applications. , 2005, Current opinion in chemical biology.

[132]  E. Ward,et al.  Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. , 1997, Journal of immunology.

[133]  J. Shendure,et al.  Advanced sequencing technologies: methods and goals , 2004, Nature Reviews Genetics.

[134]  D. Gianolio,et al.  Tethered naphthalene diimide-based intercalators for DNA triplex stabilization. , 2000, Nucleic acids research.

[135]  Dalia Cohen,et al.  Functional genomics to new drug targets , 2004, Nature Reviews Drug Discovery.

[136]  David R. Liu,et al.  Reaction discovery enabled by DNA-templated synthesis and in vitro selection , 2004, Nature.

[137]  U. Ribel,et al.  Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. , 1995, The Biochemical journal.

[138]  H. M. Geysen,et al.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[139]  E. Ward,et al.  Transcytosis and catabolism of antibody , 2002, Immunologic research.

[140]  M. Heller.  DNA microarray technology: devices, systems, and applications. , 2002, Annual review of biomedical engineering.

[141]  R. Stoughton.  Applications of DNA microarrays in biology. , 2005, Annual review of biochemistry.

[142]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[143]  S. Curry,et al.  Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. , 2000, Journal of molecular biology.

[144]  A. Hamilton,et al.  Self-assembly of bivalent protein-binding agents based on oligonucleotide-linked organic fragments. , 2005, Bioorganic & medicinal chemistry letters.

[145]  Dario Neri,et al.  Design and synthesis of a novel DNA-encoded chemical library using Diels-Alder cycloadditions. , 2008, Bioorganic & medicinal chemistry letters.

[146]  S L Morrison,et al.  Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. , 1995, Biochemistry.

[147]  L. Gold,et al.  RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[148]  S. Curry,et al.  Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.

[149]  P. Brick,et al.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites , 1998, Nature Structural Biology.

[150]  J. Andersen,et al.  The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH‐dependent binding to albumin , 2006, European journal of immunology.

[151]  B A Kenny,et al.  The application of high-throughput screening to novel lead discovery. , 1998, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[152]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[153]  D. Banabic,et al.  Recent advances and applications , 2004 .

[154]  N. Anderson,et al.  HISTORY, CHARACTER, AND DIAGNOSTIC PROSPECTS* , 2002 .

[155]  P. Aich,et al.  Thermodynamic and kinetic studies of the formation of triple helices between purine-rich deoxyribo-oligonucleotides and the promoter region of the human c-src proto-oncogene. , 1998, Nucleic acids research.

[156]  Kit S. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.